Instalab
logoInstalab

Peak METs

Your most reliable read on long-term survival, often more telling than any blood test.

Should you take a Peak METs test?

This test is most useful if any of these apply to you.

Worried About Your Heart
This test gives you the strongest functional signal of cardiovascular risk and survival, often beyond what resting blood tests can show.
Pushing Your Fitness Further
Get an objective measurement of your aerobic capacity and track whether your training is actually moving the needle over time.
Heading Into Major Surgery
An objective measurement of your exercise capacity predicts perioperative risk far more reliably than self-reported activity questionnaires.
Healthy but Want to Stay Ahead
Each one-unit gain in peak capacity is linked to roughly 13 to 20 percent lower mortality, making this one of the most actionable numbers you can track.

About Peak METs

Of every common measurement a doctor can take, your peak exercise capacity is one of the strongest predictors of how long you will live. In large studies of adults with and without heart disease, each one-unit increase in peak exercise capacity is linked to roughly 13 to 20 percent lower risk of dying from any cause. Few blood tests come close to that kind of signal.

Peak METs (peak metabolic equivalents of task) captures the highest workload your body reaches during a graded treadmill or cycle test. It does not test one organ in isolation. It tests the whole system at once: your heart's pumping ability, your lungs' gas exchange, and your muscles' ability to use oxygen to make energy.

What Peak METs Actually Measure

One MET equals the energy your body uses sitting quietly. Walking briskly might be 3 to 4 METs. Jogging might be 8 to 10. The gold-standard way to measure peak METs is cardiopulmonary exercise testing (CPET), where you breathe into a mask while exercising to exhaustion and your peak oxygen consumption is converted into METs. Treadmill stress tests without gas analysis estimate peak METs from the speed and grade you reach.

Self-reported tools like questionnaires routinely overestimate peak METs by two to three METs compared with actual measurement. In presurgical clinics, subjectively estimated capacity averaged 7.6 METs while measured capacity was 6.7 METs. The number you reach on a real exercise test is far more honest than the number you would guess from describing your activities.

All-Cause Mortality

This is where peak METs earns its reputation. In a meta-analysis of patients with cardiovascular disease, each one-MET higher peak capacity was linked to a hazard ratio of about 0.81 for dying from any cause, meaning roughly 19 percent lower risk per MET. In a study of more than 15,000 male veterans (both Black and white), each one-MET increase reduced mortality risk by about 13 percent, and the relationship was nearly identical across races.

In an analysis of more than 120,000 adults undergoing exercise treadmill testing, moving from the lowest fitness group to the elite group was linked to large reductions in long-term mortality, with no observed upper limit of benefit. Higher fitness kept paying off.

Heart Disease and Cardiovascular Events

Lower peak METs track tightly with worse coronary artery disease. In one study, peak VO2 (the oxygen-uptake basis for peak METs) was strongly and inversely linked to the angiographic severity of coronary disease. Among childhood cancer survivors, each one-MET higher peak capacity was linked to roughly 20 percent lower risk of a new cardiovascular event, and those who later died of cardiovascular causes had markedly lower peak METs than survivors.

Peak METs also unmasks subclinical heart trouble that resting tests miss. In asymptomatic adults with type 2 diabetes, exercise testing combined with stress echocardiography raised detection of subclinical heart failure from 68 percent (at rest) to 79 percent. People with lower peak METs (7.3 versus 8.8) were the ones with abnormal diastolic function on stress.

Surgical Risk

In presurgical clinics, a peak capacity at or below roughly 4 to 4.6 METs is used as a threshold for low functional capacity, which carries higher perioperative risk. Brief, submaximal CPET is feasible in this setting and detects low capacity that questionnaires miss. If you are heading into major surgery, an objective peak METs measurement is far more reliable than your self-assessment of how many flights of stairs you can climb.

Reference Ranges

Peak METs varies meaningfully by age and sex, and reference values come from large registries like the Fitness Registry and the Importance of Exercise National Database (FRIEND), which pooled data from over 22,000 adults. Treadmill standards in the updated US dataset were 1.5 to 4.6 mL/kg/min (roughly 0.4 to 1.3 METs) lower than the previous standards. The ranges below are illustrative orientation drawn from clinical exercise testing literature. Your individual targets depend on age and sex, and your lab may report slightly different numbers.

CategoryApproximate Peak METsWhat It Suggests
Low functional capacity≤4 to 4.6Higher perioperative and long-term mortality risk; warrants investigation
Below average4.6 to 7Below typical fitness for most adults; meaningful room to improve
Average to above average7 to 10Typical adult range; protective compared with low fitness
High to eliteAbove 10Strongly associated with the lowest mortality, with no upper limit of benefit observed

Source: thresholds drawn from coronary artery disease and preoperative cohorts and the FRIEND registry (Kaminsky et al. 2021; Carr et al. 2024; Mandsager et al. 2018). Compare your results within the same testing protocol over time for the most meaningful trend.

Why Tracking Matters More Than a Single Reading

Peak METs is a moving target, and the trend tells you more than any single number. In a cardiac rehabilitation cohort of more than 8,000 adults, those who maintained a gain of at least 0.5 MET one year after rehabilitation had improved survival, regardless of how many other conditions they had. In community-dwelling adults, modeling suggests that as little as 10 minutes per day of vigorous activity is linked to roughly 0.8 to 1.1 METs higher peak fitness.

A reasonable cadence: get a baseline test, retest in 3 to 6 months if you are actively training or recovering from a cardiac event, and at least annually thereafter. Small, sustained gains add up to real changes in your survival curve.

What to Do With an Abnormal Result

If your peak METs is unexpectedly low for your age and sex, the next step is not just to train harder. It is to find out why. Low capacity can reflect deconditioning, but it can also flag undiagnosed coronary disease, heart failure with preserved ejection fraction, valve disease, anemia, lung disease, or thyroid dysfunction. Companion workup typically includes a resting ECG, complete blood count, basic metabolic panel, thyroid function, and a lipid panel with ApoB (apolipoprotein B). If symptoms are present or the test was abnormal during exercise, a cardiology referral and consideration of stress imaging or coronary calcium scoring is reasonable.

In the CAC-FIT study, combining coronary artery calcium scoring with peak exercise capacity refined risk beyond either test alone. A high calcium score with low fitness is a far worse picture than a high score with preserved fitness.

When Results Can Be Misleading

A single peak METs result can mislead you in several ways. The most common pitfalls:

  • Stopping the test too early: in healthy workers, ending the exercise test at 85 percent of predicted maximum heart rate rather than at volitional exhaustion nearly halved the detection of cardiovascular abnormalities. If your test was stopped early, your reported peak METs underestimates your true capacity.
  • Estimated rather than measured: the Bruce treadmill protocol systematically overestimates aerobic capacity in patients with suspected ischemia, which can falsely reassure. Direct gas measurement (CPET) is more accurate.
  • Beta-blockers and rate-limiting medications: these can blunt the heart rate response and shorten effort, lowering your reported peak METs without indicating new heart disease. The reading reflects medication physiology, not necessarily an underlying decline.
  • Recent illness or poor sleep: acute infection, dehydration, or a bad night before the test can transiently lower peak performance by a meaningful margin. A single dip is not a trend.

Self-report based scores like the Duke Activity Status Index correlate only weakly with measured peak METs. If you are making a major medical decision, get the real number.

What Moves This Biomarker

Evidence-backed interventions that affect your Peak METs level

Increase
Structured cardiac rehabilitation and aerobic exercise training
Sustained aerobic training reliably raises peak METs, which is the most consistent way to improve your long-term survival number. Cardiac rehabilitation cohorts typically show gains of 0.8 to 1.0 MET after roughly 12 weeks of supervised training, and maintaining at least a 0.5-MET gain one year out was linked to improved survival in a cohort of more than 8,000 adults, regardless of how many other conditions they had.
ExerciseModerate Evidence
Increase
Daily vigorous physical activity
Even small amounts of vigorous activity add up. Modeling in 103 adults suggested that replacing sedentary time with as little as 10 minutes per day of vigorous activity predicted roughly 0.8 to 1.1 MET higher peak capacity, a clinically meaningful gain associated with lower mortality risk.
ExerciseModerate Evidence
Increase
Reducing daily sedentary and stationary time
Habitual sedentary time was inversely related to aerobic fitness in 103 adults, and substituting sedentary minutes with more active behaviors predicted higher peak capacity. The size of the effect is smaller than dedicated training but acts on the time you spend across the entire day, not just during workouts.
LifestyleModest Evidence
Increase
Mavacamten (cardiac myosin inhibitor) for obstructive hypertrophic cardiomyopathy
In a randomized trial of 251 adults with obstructive hypertrophic cardiomyopathy, mavacamten increased peak METs by about 0.4 over 30 weeks compared with placebo, alongside broader improvements in cardiopulmonary exercise testing parameters. This intervention is specific to obstructive hypertrophic cardiomyopathy and is not relevant to peak METs in the general population.
MedicationModest Evidence
Increase
Albiglutide (GLP-1 receptor agonist) in heart failure with reduced ejection fraction
In 82 adults with chronic heart failure and reduced ejection fraction, 12 weeks of albiglutide raised peak oxygen consumption by about 1.5 mL/kg/min compared with placebo, equating to roughly 0.4 MET higher peak capacity. Six-minute walk distance did not change, so the functional translation of this gain is unclear.
MedicationModest Evidence
Increase
Strength training with progressive resistance
In a randomized trial of 179 community-dwelling older adults, strength training improved muscle performance and fatigue resistance, which contribute to higher exercise capacity. Statin users actually showed better fatigue resistance than non-users, suggesting statins do not blunt training gains.
ExerciseModest Evidence

Frequently Asked Questions

References

24 studies
  1. Ezzatvar Y, Izquierdo M, Núñez J, Calatayud J, Ramírez-vélez R, García-hermoso aJournal of Sport and Health Science2021
  2. Ahmed a, Saad J, Han Y, Alfawara M, Soliman a, Nabi F, Zoghbi W, Al-mallah MMayo Clinic Proceedings2022
  3. Ozemek C, Arena R, Rouleau C, Campbell T, Hauer T, Wilton S, Stone J, Laddu D, Williamson T, Liu H, Chirico D, Austford L, Aggarwal SJournal of Cardiopulmonary Rehabilitation and Prevention2022
  4. Wogksch MD, Ware ME, Onerup a, O'neil ST, Nolan VG, Smeltzer MP, Mzayek F, Mulrooney D, Ehrhardt M, Dixon S, Rhea IB, Srivastava D, Armstrong GT, Hudson M, Ness KKMedicine and Science in Sports and Exercise2025
  5. Mandsager K, Harb S, Cremer P, Phelan D, Nissen S, Jaber WJAMA Network Open2018